BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1377669)

  • 1. The inhibitory effect of the combination of antineoplaston A-10 injection with a small dose of cis-diamminedichloroplatinum on cell and tumor growth of human hepatocellular carcinoma.
    Tsuda H; Sugihara S; Nishida H; Hara H; Eriguchi N; Ishii K; Sasaki K; Yoshimura S; Tanaka N
    Jpn J Cancer Res; 1992 May; 83(5):527-31. PubMed ID: 1377669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of antineoplaston A-10 on breast cancer transplanted to athymic mice and human hepatocellular carcinoma cell lines. The members of Antineoplaston Study Group.
    Tsuda H
    Kurume Med J; 1990; 37(2):97-104. PubMed ID: 2175003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10.
    Qu XJ; Cui SX; Tian Z; Li X; Chen MH; Xu WF; Inagaki Y; Deng YB; Makuuchi M; Nakata M; Tang W
    Anticancer Res; 2007; 27(4B):2427-31. PubMed ID: 17695534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo.
    Kojima M; Kikkawa F; Oguchi H; Mizuno K; Maeda O; Tamakoshi K; Ishikawa H; Kawai M; Suganuma N; Tomoda Y
    Eur J Cancer; 1994; 30A(6):773-8. PubMed ID: 7917536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil enhancement of antitumor effect of cis-diamminedichloroplatinum(II) in nude mouse-grown human neuroblastoma.
    Ikeda H; Nakano G; Nagashima K; Sakamoto K; Harasawa N; Kitamura T; Nakamura T; Nagamachi Y
    Cancer Res; 1987 Jan; 47(1):231-4. PubMed ID: 3791210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplaston treatment for advanced hepatocellular carcinoma.
    Kumabe T; Tsuda H; Uchida M; Ogoh Y; Hayabuchi N; Sata M; Nakashima O; Hara H
    Oncol Rep; 1998; 5(6):1363-7. PubMed ID: 9769368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
    Xi S; Peng Y; Minuk GY; Shi M; Fu B; Yang J; Li Q; Gong Y; Yue L; Li L; Guo J; Peng Y; Wang Y
    J Ethnopharmacol; 2016 Aug; 190():1-12. PubMed ID: 27235019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticancer effect of antineoplaston A-10 on human breast cancer serially transplanted to athymic mice.
    Hashimoto K; Koga T; Shintomi Y; Tanaka M; Kakegawa T; Tsuda H; Hara H
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):1-5. PubMed ID: 2157780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
    Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
    Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental chemotherapy of human testicular carcinoma transplanted in nude mice].
    Yanagisawa M; Machida T; Miki M; Tanino M; Akasaka Y; Higashi Y; Kondo N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1299-307. PubMed ID: 6191680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.
    Nakata H; Kikuchi Y; Tode T; Hirata J; Kita T; Ishii K; Kudoh K; Nagata I; Shinomiya N
    Jpn J Cancer Res; 1998 Jul; 89(7):733-40. PubMed ID: 9738980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma.
    Tsuda H; Iemura A; Sata M; Uchida M; Yamana K; Hara H
    Kurume Med J; 1996; 43(2):137-47. PubMed ID: 8755117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentinan enhances sensitivity of mouse colon 26 tumor to cis-diamminedichloroplatinum (II) and decreases glutathione transferase expression.
    Murata T; Hatayama I; Kakizaki I; Satoh K; Sato K; Tsuchida S
    Jpn J Cancer Res; 1996 Nov; 87(11):1171-8. PubMed ID: 9045947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of QHF-cisplatin against hepatocellular carcinoma in a mouse model.
    Chen T; Yuan SJ; Wang J; Hu W
    World J Gastroenterol; 2015 Sep; 21(35):10126-36. PubMed ID: 26401077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
    Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
    van Moorsel CJ; Pinedo HM; Veerman G; Bergman AM; Kuiper CM; Vermorken JB; van der Vijgh WJ; Peters GJ
    Br J Cancer; 1999 Jun; 80(7):981-90. PubMed ID: 10362105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma.
    Zhu BD; Yuan SJ; Zhao QC; Li X; Li Y; Lu QY
    World J Gastroenterol; 2005 Mar; 11(9):1382-6. PubMed ID: 15761981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
    Mizutani Y; Bonavida B
    Cancer; 1993 Aug; 72(3):809-18. PubMed ID: 8334635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents.
    Hata Y; Takada N; Sasaki F; Abe T; Hamada H; Takahashi H; Uchino J; Tsukada Y
    J Pediatr Surg; 1992 Jun; 27(6):724-7. PubMed ID: 1380075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.